Literature DB >> 25869806

Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients.

J Frank, M Lang, S H Witt, J Strohmaier, D Rujescu, S Cichon, F Degenhardt, M M Nöthen, D A Collier, S Ripke, D Naber, M Rietschel.   

Abstract

Entities:  

Year:  2015        PMID： 25869806     DOI： 10.1038/mp.2015.52

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  13 in total

Review 1.  What Next in Schizophrenia Genetics for the Psychiatric Genomics Consortium?

Authors:  Aiden Corvin; Patrick F Sullivan
Journal:  Schizophr Bull       Date:  2016-03-18       Impact factor: 9.306

Review 2.  Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.

Authors:  Ryan Bogdan; David A A Baranger; Arpana Agrawal
Journal:  Annu Rev Clin Psychol       Date:  2018-05-07       Impact factor: 18.561

3.  Polygenic Scores in Epidemiology: Risk Prediction, Etiology, and Clinical Utility.

Authors:  Brion S Maher
Journal:  Curr Epidemiol Rep       Date:  2015-09-28

4.  Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia.

Authors:  Thomas P White; Rebekah Wigton; Dan W Joyce; Tracy Collier; Alex Fornito; Sukhwinder S Shergill
Journal:  Neuropsychopharmacology       Date:  2015-09-09       Impact factor: 7.853

5.  Response to therapeutic sleep deprivation: a naturalistic study of clinical and genetic factors and post-treatment depressive symptom trajectory.

Authors:  Nina Trautmann; Jerome C Foo; Josef Frank; Stephanie H Witt; Fabian Streit; Jens Treutlein; Steffen Conrad von Heydendorff; Maria Gilles; Andreas J Forstner; Ulrich Ebner-Priemer; Markus M Nöthen; Michael Deuschle; Marcella Rietschel
Journal:  Neuropsychopharmacology       Date:  2018-05-17       Impact factor: 7.853

Review 6.  Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches.

Authors:  Claudia Pisanu; Alessio Squassina
Journal:  Front Pharmacol       Date:  2019-05-29       Impact factor: 5.810

7.  Evidence for increased genetic risk load for major depression in patients assigned to electroconvulsive therapy.

Authors:  Jerome C Foo; Fabian Streit; Josef Frank; Stephanie H Witt; Jens Treutlein; Bernhard T Baune; Susanne Moebus; Karl-Heinz Jöckel; Andreas J Forstner; Markus M Nöthen; Marcella Rietschel; Alexander Sartorius; Laura Kranaster
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-12-02       Impact factor: 3.568

Review 8.  The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data.

Authors:  Eduardo S Gouvêa; Airton F Santos; Vanessa K Ota; Vinicius Mrad; Ary Gadelha; Rodrigo A Bressan; Quirino Cordeiro; Sintia I Belangero
Journal:  Braz J Psychiatry       Date:  2017-01-12       Impact factor: 2.697

Review 9.  The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology.

Authors:  Olav B Smeland; Oleksandr Frei; Anders M Dale; Ole A Andreassen
Journal:  Nat Rev Neurol       Date:  2020-06-11       Impact factor: 42.937

Review 10.  Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects.

Authors:  Antonio Rampino; Aleksandra Marakhovskaia; Tiago Soares-Silva; Silvia Torretta; Federica Veneziani; Jean Martin Beaulieu
Journal:  Front Psychiatry       Date:  2019-01-09       Impact factor: 4.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.